[Report of clinical testing of BCG vaccine (Strain "1331 Copenhagen") for vaccination of newborns against tuberculosis (author's transl)].
BCG vaccination with the vaccine "1331 Copenhagen" in various concentrations was carried out in 129 newborns. Control examinations were conducted to establish the complication rate and the percentage of tuberculin-positive children. Complications, either locally or in regional lymphatic areas, did not appear. The conversion rate increased with the number of viable units pro dose of vaccine. A vaccine with a concentration of about 250,000 units of vaccine pro dose is recommended for additional clinical testing.
D001500:BCG Vaccine / Q000592:standards*; D001724:Birth Weight; D002986:Clinical Trials as Topic; D005500:Follow-Up Studies; D006801:Humans; D007115:Immunization Schedule; D007223:Infant; D007231:Infant, Newborn; D008199:Lymphadenitis / Q000209:etiology; D013997:Time Factors; D014374:Tuberculin Test
D001500:BCG Vaccine
Bericht über die klinische Prüfung der BCG-Vakzine Stamm "1331 Kopenhagen" zur Impfung von Neugeborenen gegen Tuberkulose